comparemela.com

Page 7 - Astaa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Broadwood Partners, L P Acquires 34,320 Shares of STAAR Surgical (NASDAQ:STAA) Stock

STAAR Surgical (NASDAQ:STAA – Get Free Report) major shareholder Broadwood Partners, L.P. acquired 34,320 shares of the company’s stock in a transaction that occurred on Friday, November 10th. The stock was purchased at an average cost of $32.73 per share, for a total transaction of $1,123,293.60. Following the acquisition, the insider now owns 10,102,337 shares […]

StockNews com Upgrades STAAR Surgical (NASDAQ:STAA) to Hold

StockNews.com upgraded shares of STAAR Surgical (NASDAQ:STAA – Free Report) from a sell rating to a hold rating in a research note published on Friday morning. Several other equities analysts have also weighed in on STAA. Stifel Nicolaus cut their target price on STAAR Surgical from $45.00 to $40.00 and set a hold rating on […]

STAAR Surgical (NASDAQ:STAA) PT Lowered to $40 00

STAAR Surgical (NASDAQ:STAA – Free Report) had its price objective lowered by Piper Sandler from $45.00 to $40.00 in a research report released on Thursday, Benzinga reports. The brokerage currently has a neutral rating on the medical instruments supplier’s stock. Several other research firms have also recently weighed in on STAA. Benchmark cut shares of […]

Janney Montgomery Scott LLC Purchases Shares of 4,924 STAAR Surgical (NASDAQ:STAA)

Janney Montgomery Scott LLC purchased a new stake in shares of STAAR Surgical (NASDAQ:STAA – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 4,924 shares of the medical instruments supplier’s stock, valued at approximately $259,000. Other institutional investors have also added […]

Needham & Company LLC Trims STAAR Surgical (NASDAQ:STAA) Target Price to $49 00

STAAR Surgical (NASDAQ:STAA – Get Free Report) had its target price cut by equities research analysts at Needham & Company LLC from $52.00 to $49.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage presently has a “buy” rating on the medical instruments supplier’s stock. Needham & Company LLC’s price objective […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.